Core Insights - Yunnan Baiyao's "Digital Cloud Medicine" platform is projected to achieve a cumulative transaction volume exceeding 2 billion yuan by December 2025, indicating significant progress in the digital transformation of the traditional Chinese medicine industry [1] - Chairman Zhang Wenhua emphasized the platform's role in leading the construction of GAP bases across a wider range of varieties in Yunnan province, promoting standardized planting and sustainable development in the Chinese medicinal materials industry [1] Management Overview - Zhang Wenhua, born in June 1963, is the current Chairman of Yunnan Baiyao Group, with a background in various leadership roles within the chemical and pharmaceutical industries [2] - Dong Ming, born in October 1976, serves as the CEO and Vice Chairman of Yunnan Baiyao Group, previously holding significant positions at Huawei Technologies [2][3] Board Elections - On November 10, Yunnan Baiyao announced the election of Zhang Wenhua as Chairman and Dong Ming as Vice Chairman of the 11th Board of Directors, with a term of three years [3] - Prior to Zhang's official appointment, Dong Ming acted as the Chairman of the Board [3]

Core Insights - Yunnan Baiyao's "Digital Cloud Medicine" platform is projected to achieve a cumulative transaction volume exceeding 2 billion yuan by December 2025, indicating significant progress in the digital transformation of the traditional Chinese medicine industry [1] - The platform has engaged over 400,000 growers, with more than 22,000 registered online farmers, serving as a crucial link between traditional cultivation and modern market demands [1]

Core Viewpoint - The company has entered into a strategic cooperation framework agreement with Shenzhen Qianhai Pengfeng Industrial Technology Co., Ltd. to explore opportunities in the digital transformation of the traditional Chinese medicine industry and asset value enhancement [1] Group 1: Strategic Cooperation - The agreement aims to establish a long-term strategic partnership focusing on the digital upgrade and platform operation of the traditional Chinese medicine industry [1] - The collaboration will involve technical and business cooperation related to the digitalization of physical assets [1] - Both parties will work together to expand the domestic and international markets for traditional Chinese medicine and related products [1] - The agreement includes discussions on multi-level capital cooperation, including equity investment [1] Group 2: Business Impact - The board believes that this strategic cooperation will extend and apply the company's capabilities in physical asset management and supply chain services without altering its existing main business [1] - The partnership aims to explore digital management and platform operation models in the field of traditional Chinese medicine and related physical assets, enhancing asset management efficiency and supply chain transparency [1] - By leveraging synergies in technology, platforms, and market resources with the partner, the company can further expand its business scenarios in the related industry chain, enhancing its overall competitiveness in the healthcare and related supply chain service sectors, ultimately creating long-term value for shareholders [1]

Core Viewpoint - The company has entered into a strategic cooperation framework agreement with Shenzhen Qianhai Pengfeng Industrial Technology Co., Ltd. to explore opportunities in the digital transformation and asset value enhancement of the traditional Chinese medicine industry [1] Group 1: Strategic Cooperation - The agreement aims to establish a long-term strategic partnership focusing on the digital upgrade and platform operation of the traditional Chinese medicine industry [1] - Key areas of collaboration include digitalization of physical assets, joint market expansion for traditional Chinese medicine and related products, and exploring multi-level capital cooperation including equity investment [1] Group 2: Business Operations and Expertise - The company primarily engages in financing leasing services for medical equipment, maternal and infant care services, and trade of medical devices and consumables in China [1] - The board believes that this strategic cooperation will enhance the company's capabilities in asset management and supply chain services without altering its existing core business [1] - The collaboration is expected to improve asset management efficiency and supply chain transparency in the field of traditional Chinese medicine [1] Group 3: Long-term Value Creation - Through synergy in technology, platforms, and market resources with the partner, the company aims to expand its business landscape in the healthcare and related supply chain service sectors [2] - The board considers the terms of the framework agreement to be fair and reasonable, aligning with the overall interests of the company and its shareholders [2]

Core Viewpoint - The company, Ziyuan Yuan (08223), has entered into a strategic cooperation framework agreement with Shenzhen Qianhai Pengfeng Industrial Technology Co., Ltd. to explore opportunities in the digital transformation of the traditional Chinese medicine industry and asset value enhancement [1] Group 1: Strategic Cooperation Details - The agreement aims to establish a long-term strategic partnership focusing on the following areas: digital upgrade and platform operation of the traditional Chinese medicine industry, collaboration on digitalization of physical assets, expansion of domestic and international markets for traditional Chinese medicine and related products, and exploration of multi-level capital cooperation including equity investment [1] - The board believes that this strategic cooperation will extend and apply the company's capabilities in physical asset management and supply chain services without altering its existing main business [1] Group 2: Expected Outcomes - The collaboration is expected to enhance asset management efficiency and supply chain transparency through digital management and platform operation models in the field of traditional Chinese medicine and related physical assets [1] - By leveraging synergies in technology, platforms, and market resources with the partner, the company aims to further expand its business scenarios in the related industry chain and enhance its overall competitiveness in the healthcare and related supply chain service sectors, ultimately creating long-term value for shareholders [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或 完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該 等內容而引致的任何損失承擔任何責任。 Ziyuanyuan Holdings Group Limited 紫元元控股集團有限公司 （於開曼群島註冊成立的有限公司） （股份代號：8223） 自願性公告 有關訂立戰略合作框架協議 本公告乃由紫元元控股集團有限公司（「本公司」），連同其附屬公司統稱「本集團」）自願刊 發，旨在告知本公司股東及潛在投資者有關本集團最新業務發展。 訂立戰略合作框架協議 本公司董事（「董事」）會（「董事會」）欣然宣佈，於二零二五年十二月二十三日，本公司與 深圳前海鵬峰實業科技有限公司（「鵬峰科技」）訂立戰略合作框架協議（「框架協議」），雙 方同意建立長期戰略合作關係，共同探索中藥材產業數字化轉型及資產價值提升等領域的合作機 遇。 據董事經作出一切合理查詢後所知、所悉及所信，於本公告日期，鵬峰科技及其最終實益擁有人 均為獨立於本公司及其關連人士（定義見香港聯合交易所有限公司證券 GEM 上市規則（「GEM 上 市規則」）） ...